Document is current
Any future updates will be listed below
-
Authors
Alpaugh, Melanie
Galleguillos, Danny
Forero, Juan
Morales, Luis Carlos
Lackey, Sebastian W
Kar, Preeti
Di Pardo, Alba
Holt, Andrew
Kerr, Bradley J
Todd, Kathryn G
Baker, Glen B
Fouad, Karim
Sipione, Simonetta https://orcid.org/0000-0002-3060-0723
-
Funding
Funding for this research was provided by:
Huntington Society of Canada
Canada Research Chair
Canadian Institutes of Health Research (MOP 111219)
Canadian Institutes of Health Research (PDD 115217)
Alberta Innovates – Health Solutions
- License Information
-
More Information
Article History
Received: 1 March 2017
Revised: 6 September 2017
Accepted: 8 September 2017
First Online: 9 October 2017
Conflict of interest
: SS holds a non‐provisional US patent for the use of GM1 in treating HD. SS and the other authors declare no other financial interests or potential conflict of interest.
